The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher (CNPV) programme, a fast track for medicines that could deliver a decision on ...

I spent the last week of March 2026 in San Francisco talking to CTOs, CPOs, and engineering leaders from companies of every ...

Google’s decision to move up its timeline for migration to post-quantum cryptography highlights that some of the cyber ...